Skip to main content
. 2024 Oct 2;25:777. doi: 10.1186/s12891-024-07894-0

Table 3.

Patient-reported outcomes in patients

CC group NC group P-value t-value
mHHS
Preoperative 57.88 ± 6.82 58.36 ± 7.72 0.742 -0.330
6th month of follow-up 76.76 ± 3.82 71.86 ± 5.98 < 0.001 4.885
12th month of follow-up 86.08 ± 2.75 82.48 ± 4.09 < 0.001 5.165
HOS-SSS
Preoperative 40.94 ± 5.79 42.11 ± 6.36 0.340 0.958
6th month of follow-up 74.38 ± 5.06 68.61 ± 8.84 < 0.001 5.984
12th month of follow-up 86.16 ± 4.39 82.72 ± 4.90 < 0.001 3.697
HOS-ADL
Preoperative 51.14 ± 5.48 51.57 ± 4.88 0.679 0.415
6th month of follow-up 76.82 ± 3.94 72.28 ± 6.37 < 0.001 4.279
12th month of follow-up 88.82 ± 2.66 84.85 ± 5.16 < 0.001 4.840
VAS
Preoperative 5.56 ± 0.76 5.48 ± 0.84 0.618 0.500
6th month of follow-up 2.22 ± 0.65 2.78 ± 0.79 < 0.001 3.875
12th month of follow-up 0.86 ± 0.70 1.44 ± 0.91 < 0.001 3.579

Note Data are presented as Inline graphicS standard deviation. mHHS, modified Harris Hip Score; HOS-SSS, Hip Outcome Score Sport-Specific Subscale; HOS-ADL, the hip function score for daily activities; VAS, visual analog scale. Statistically significant (P < 0.05). CC group: shoelace capsular closure group; NC group: non-capsular closure group.